home > events calendar > more about event

Clinical Trials Europe | Partnerships, Outsourcing, Operations & Technology

KNect 365

27 August - 21 November 2019
Barcelona, Spain

On 19-21 November 2019, the clinical trial community's most influential stakeholders will be meeting in Barcelona to discuss the evolving landscape, honing in on what it takes to harness true value from partnerships, outsourcing, operations, technology and early clinical development, for a faster, more efficient route to market.

Exploring the latest strategies, tools and innovative approaches, Clinical Trials Europe digs deep into the practical solutions to every day challenges as well as those that are more unique, to help you identify new and tried-and-tested approaches to better fulfil your clinical trial activities.

Join Pharma, Biotech, CROs, Patient Groups, Suppliers, Technology Providers and Consortiums for the rare opportunity to get a comprehensive industry update from all of the key perspectives, expand your professional network, and tackle the challenges head-on.

Plus, with leading insights and success stories from an 120+ expert speaker line-up from the likes of Allergan, AstraZeneca, Bill & Melinda Gates Medical Research Institute, Eisai, The FDA, Leo Innovation Lab, Merck, Novartis, Pfizer, Roche, Sanofi, Servier, Tufts Centre for the Study of Drug Development Tufts University and more, take the opportunity to get your questions answered and ensure you're at the forefront of clinical best practices.

Visit the Clinical Trials Europe website to see the full line-up:
email 5 Howick Place, London SW1P 1WG
Print this page
Send to a friend
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

News and Press Releases

Merck Introduces Parteck® COAT Excipient, a Fast-Dissolving Material for Immediate Release Coating

• Designed to simplify the formulation and coating process for tablets • Optimized particle size leads to fast dissolving and increases coating process efficiency Merck has launched its Parteck® COAT excipient, a new functional material designed for immediate release film coating applications. Parteck® COAT is a particle engineered polyvinyl alcohol (PVA) with a unique particle structure that enables rapid dissolution even at low temperatures leading to an increased process efficiency.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement